I had a chance to talk with Alan C. Yeung, MD, FACC of Stanford about the RESOLUTE US study just presented at the 60th Annual Scientific Session of the American College of Cardiology (ACC). He was one of the principal investigators of this study, which was just sent to the FDA as the final component of Medtronic’s approval submission package. The company is hoping for U.S. approval in the first half of 2012. You can read the full interview on Angioplasty.Org.
RESOLUTE US: Interview with PI of Medtronic’s New Stent
Filed under ACC, Interviews, Transradial Approach